Metlife Inc Pref (MET_PA)

Metlife Inc Pref (MET_pa) is a NYSE-listed preferred security issued by MetLife Inc, and it should be understood as preferred stock rather than common equity. This instrument is tied to the Financials sector and the insurance industry, so its role is different from an ordinary operating share. The security context is preferred security, which means it represents a class of capital with its own claim structure and terms. MetLife Inc is associated with insurance-related financial activities, but this listing describes the preferred security itself, not the company’s full operating profile. It trades on the NYSE under the symbol MET.PRA.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-MET.PRA
$28.90
37.5% Upside
Undervalued
Not available
Not available
Good
6.0%
November 4, 2026
18.0x
2.3x
0.8x
61.667 B
93.394 B
44.6%
83.6%
0.3
46.4%
452.1%
Valuation • Fair Value

Metlife Inc Pref (NYSE-MET.PRA) Fair Value by Valuation Model

Review the available estimates for Metlife Inc Pref (NYSE-MET.PRA), including Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$28.90

Estimated upside of 37.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

Ben Graham Formula Value

$17.60

Classic Ben Graham valuation formula reference.

DDM Fair Value

$30.61

Dividend discount model valuation reference.

Comps Fair Value

$28.33

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 5 available valuation references for Metlife Inc Pref (NYSE-MET.PRA) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Metlife Inc Pref (NYSE-MET.PRA)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

79.398 B

Current operating scale indicator.

Revenue Forecast

79.524 B

Forward revenue estimate.

EBITDA

6.04 B

Current operating profitability reference.

EBITDA Forecast

5.698 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Metlife Inc Pref (NYSE-MET.PRA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Metlife Inc Pref (NYSE-MET.PRA)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Altman Z-Score

0.3

Lower score that deserves closer risk review.

FCF / Net Income

452.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Metlife Inc Pref (NYSE-MET.PRA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Metlife Inc Pref (NYSE-MET.PRA)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 4, 2026

Days to Earnings

47

Dividend Yield

6.0%

Current income yield reference.

Payout Ratio

46.4%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Metlife Inc Pref (NYSE-MET.PRA), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Metlife Inc Pref (NYSE-MET.PRA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Metlife Inc Pref (NYSE-MET.PRA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Metlife Inc Pref (NYSE-MET.PRA) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Metlife Inc Pref (NYSE-MET.PRA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Metlife Inc Pref (NYSE-MET.PRA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Metlife Inc Pref (NYSE-MET.PRA) Stock FAQ

Data-supported answers about Metlife Inc Pref (NYSE-MET.PRA), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$28.90
Estimated upside 37.5%
Valuation Rating
Undervalued
Estimated upside of 37.5%
Financial Health
Good
Current financial-health read

The current fair value estimate for Metlife Inc Pref (NYSE-MET.PRA) is $28.90. This implies an estimated upside of 37.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 37.5% versus the current market price.

The current financial health read for Metlife Inc Pref (NYSE-MET.PRA) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Metlife Inc Pref (NYSE-MET.PRA) is November 4, 2026.

Based on the current data, dividend yield is 6.0%.

The current P/E ratio listed for Metlife Inc Pref (NYSE-MET.PRA) is 18.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Metlife Inc Pref is 61.667 B.

The current enterprise value listed for Metlife Inc Pref is 93.394 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Metlife Inc Pref is NYSE-MET.PRA, and the stock is listed on NYSE.

Metlife Inc Pref (NYSE-MET.PRA) is listed on NYSE.

The current debt-to-total-capital ratio listed for Metlife Inc Pref is 44.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Metlife Inc Pref is 83.6%. Free float helps investors understand how much of the share base is available for public trading.